ETO/MTG8 Is an Inhibitor of C/EBPβ Activity and a Regulator of Early Adipogenesis

REFERENCES

• Amann, J. M., Nip J., Strom D. K., Lutterbach B., Harada H., Lenny N., Downing J. R., Meyers S., and Hiebert S. W.. 2001. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases, and binds mSin3A through its oligomerization domain. Mol. Cell. Biol. 21:6470–6483.
   PubMed Web of Science ®Google Scholar
• Barseguian, K., Lutterbach B., Hiebert S. W., Nickerson J., Lian J. B., Stein J. L., van Wijnen A. J., and Stein G. S.. 2002. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Proc. Natl. Acad. Sci. USA 99:15434–15439.
   PubMed Web of Science ®Google Scholar
• Calabi, F., Pannell R., and Pavloska G.. 2001. Gene targeting reveals a crucial role for MTG8 in the gut. Mol. Cell. Biol. 21:5658–5666.
   PubMed Web of Science ®Google Scholar
• Calkhoven, C. F., Muller C., and Leutz A.. 2000. Translational control of C/EBPα and C/EBPβ isoform expression. Genes Dev. 14:1920–1932.
   PubMed Web of Science ®Google Scholar
• Chevallier, N., Corcoran C. M., Lennon C., Haijek E., Chadburn A., Bardwell V. J., Licht J. D., and Melnick A.. 2003. The ETO protein of t(8;21) AML is a corepressor for the Bcl-6 B-cell lymphoma oncoprotein. Blood.
   Google Scholar
• Christy, R. J., Kaestner K. H., Geiman D. E., and Lane M. D.. 1991. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 88:2593–2597.
   PubMed Web of Science ®Google Scholar
• Clarke, S. L., Robinson C. E., and Gimble J. M.. 1997. CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. Biochem. Biophys. Res. Commun. 240:99–103.
   PubMed Web of Science ®Google Scholar
• Cole, K. A., Harmon A. W., Harp J. B., and Patel Y. M.. 2004. Rb regulates C/EBPβ-DNA-binding activity during 3T3-L1 adipogenesis. Am. J. Physiol. Cell Physiol. 286:C349–C354.
   PubMedGoogle Scholar
• Davis, J. N., McGhee L., and Meyers S.. 2003. The ETO (MTG8) gene family. Gene 303:1–10.
   PubMed Web of Science ®Google Scholar
• Descombes, P., and Schibler U.. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569–579.
   PubMed Web of Science ®Google Scholar
• Elberg, G., Gimble J. M., and Tsai S. Y.. 2000. Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins. J. Biol. Chem. 275:27815–27822.
   PubMed Web of Science ®Google Scholar
• Erickson, R. L., Hemati N., Ross S. E., and MacDougald O. A.. 2001. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. J. Biol. Chem. 276:16348–16355.
   PubMedGoogle Scholar
• Hadaschik, D., Hinterkeuser K., Oldak M., Pfister H. J., and Smola-Hess S.. 2003. The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 77:5253–5265.
   PubMedGoogle Scholar
• Hamm, J. K., Park B. H., and Farmer S. R.. 2001. A role for C/EBPβ in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J. Biol. Chem. 276:18464–18471.
   PubMed Web of Science ®Google Scholar
• Hartman, H. B., Hu X., Tyler K. X., Dalal C. K., and Lazar M. A.. 2002. Mechanisms regulating adipocyte expression of resistin. J. Biol. Chem. 277:19754–19761.
   PubMedGoogle Scholar
• Herzig, S., Long F., Jhala U. S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., and Montminy M.. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:179–183.
   PubMed Web of Science ®Google Scholar
• Kahn, B. B., and Flier J. S.. 2000. Obesity and insulin resistance. J. Clin. Investig. 106:473–481.
   PubMed Web of Science ®Google Scholar
• Lamb, J., Ramaswamy S., Ford H. L., Contreras B., Martinez R. V., Kittrell F. S., Zahnow C. A., Patterson N., Golub T. R., and Ewen M. E.. 2003. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323–334.
   PubMed Web of Science ®Google Scholar
• Licht, J. D. 2001. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene 20:5660–5679.
   PubMed Web of Science ®Google Scholar
• Liu, S., Croniger C., Arizmendi C., Harada-Shiba M., Ren J., Poli V., Hanson R. W., and Friedman J. E.. 1999. Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPβ gene. J. Clin. Investig. 103:207–213.
   PubMedGoogle Scholar
• Lutterbach, B., Sun D., Schuetz J., and Hiebert S. W.. 1998. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol. Cell. Biol. 18:3604–3611.
   PubMed Web of Science ®Google Scholar
• Marshall, J., Dolan B. M., Garcia E. P., Sathe S., Tang X., Mao Z., and Blair L. A.. 2003. Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPβ levels to control neuronal survival. Neuron 39:625–639.
   PubMedGoogle Scholar
• McKnight, S. L. 2001. McBindall: a better name for CCAAT/enhancer binding proteins? Cell 107:259–261.
   PubMedGoogle Scholar
• Moitra, J., Mason M. M., Olive M., Krylov D., Gavrilova O., Marcus-Samuels B., Feigenbaum L., Lee E., Aoyama T., Eckhaus M., Reitman M. L., and Vinson C.. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12:3168–3181.
   PubMed Web of Science ®Google Scholar
• Morrison, R. F., and Farmer S. R.. 1999. Insights into the transcriptional control of adipocyte differentiation. J. Cell Biochem. Suppl. 32-33:59–67.
   Google Scholar
• Mulligan, C., Rochford J., Denyer G., Stephens R., Yeo G., Freeman T., Siddle K., and O'Rahilly S.. 2002. Microarray analysis of insulin and IGF-1 receptor signalling reveals the selective upregulation of the mitogen HB-EGF by IGF-1. J. Biol. Chem. 277:42480–42487.
   PubMed Web of Science ®Google Scholar
• Nerlov, C., McNagny K. M., Doderlein G., Kowenz-Leutz E., and Graf T.. 1998. Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes Dev. 12:2413–2423.
   PubMed Web of Science ®Google Scholar
• Odaka, Y., Mally A., Elliott L. T., and Meyers S.. 2000. Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8). Oncogene 19:3584–3597.
   PubMed Web of Science ®Google Scholar
• Petersen, K. F., Oral E. A., Dufour S., Befroy D., Ariyan C., Yu C., Cline G. W., DePaoli A. M., Taylor S. I., Gorden P., and Shulman G. I.. 2002. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Investig. 109:1345–1350.
   PubMed Web of Science ®Google Scholar
• Rajala, M. W., and Scherer P. E.. 2003. Minireview: the adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765–3773.
   PubMed Web of Science ®Google Scholar
• Rana, B., Xie Y., Mischoulon D., Bucher N. L., and Farmer S. R.. 1995. The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle. J. Biol. Chem. 270:18123–18132.
   PubMedGoogle Scholar
• Rangwala, S. M., and Lazar M. A.. 2000. Transcriptional control of adipogenesis. Annu. Rev. Nutr. 20:535–559.
   PubMed Web of Science ®Google Scholar
• Roesler, W. J. 2001. The role of C/EBP in nutrient and hormonal regulation of gene expression. Annu. Rev. Nutr. 21:141–165.
   PubMedGoogle Scholar
• Rosen, E. D., Hsu C. H., Wang X., Sakai S., Freeman M. W., Gonzalez F. J., and Spiegelman B. M.. 2002. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 16:22–26.
   PubMed Web of Science ®Google Scholar
• Rosen, E. D., and Spiegelman B. M.. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16:145–171.
   PubMed Web of Science ®Google Scholar
• Tanaka, T., Yoshida N., Kishimoto T., and Akira S.. 1997. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J. 16:7432–7443.
   PubMed Web of Science ®Google Scholar
• Tang, Q. Q., Jiang M. S., and Lane M. D.. 1997. Repression of transcription mediated by dual elements in the CCAAT/enhancer binding protein alpha gene. Proc. Natl. Acad. Sci. USA 94:13571–13575.
   PubMedGoogle Scholar
• Tang, Q. Q., Jiang M. S., and Lane M. D.. 1999. Repressive effect of Sp1 on the C/EBPα gene promoter: role in adipocyte differentiation. Mol. Cell. Biol. 19:4855–4865.
   PubMed Web of Science ®Google Scholar
• Tang, Q. Q., and Lane M. D.. 1999. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 13:2231–2241.
   PubMed Web of Science ®Google Scholar
• Tang, Q. Q., and Lane M. D.. 2000. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis. Proc. Natl. Acad. Sci. USA 97:12446–12450.
   PubMed Web of Science ®Google Scholar
• Taubenfeld, S. M., Milekic M. H., Monti B., and Alberini C. M.. 2001. The consolidation of new but not reactivated memory requires hippocampal C/EBPβ. Nat. Neurosci. 4:813–818.
   PubMed Web of Science ®Google Scholar
• Urso, B., Cope D. L., Kalloo-Hosein H. E., Hayward A. C., Whitehead J. P., O'Rahilly S., and Siddle K.. 1999. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J. Biol. Chem. 274:30864–30873.
   PubMed Web of Science ®Google Scholar
• Wang, L., Shao J., Muhlenkamp P., Liu S., Klepcyk P., Ren J., and Friedman J. E.. 2000. Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein beta. J. Biol. Chem. 275:14173–14181.
   PubMedGoogle Scholar
• Wiper-Bergeron, N., Wu D., Pope L., Schild-Poulter C., and Hache R. J.. 2003. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 22:2135–2145.
   PubMed Web of Science ®Google Scholar
• Wolford, J. K., Bogardus C., and Prochazka M.. 1998. Polymorphism in the 3′ untranslated region of MTG8 is associated with obesity in Pima Indian males. Biochem. Biophys. Res. Commun. 246:624–626.
   PubMedGoogle Scholar
• Wolford, J. K., and Prochazka M.. 1998. Structure and expression of the human MTG8/ETO gene. Gene 212:103–109.
   PubMed Web of Science ®Google Scholar
• Wu, Z., Bucher N. L., and Farmer S. R.. 1996. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol. Cell. Biol. 16:4128–4136.
   PubMed Web of Science ®Google Scholar
• Wu, Z., Rosen E. D., Brun R., Hauser S., Adelmant G., Troy A. E., McKeon C., Darlington G. J., and Spiegelman B. M.. 1999. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3:151–158.
   PubMed Web of Science ®Google Scholar